Immunohistochemical and molecular analysis favored a diagnosis of Alveolar Soft Part Sarcoma (ASPS), though TFE3 gene-rearranged PEComa could not be completely excluded. This evidence concerns the gene TFE3 and alveolar soft part sarcoma.